Britain's mid-cap industrials and specialty-materials businesses have rarely looked as exposed to corporate change as they do this autumn. Three FTSE 250 names — Tate & Lyle, Elementis and Johnson Matthey — show how Takeover interest, portfolio surgery and shifting index status are reshaping a corner of the London market that investors long treated as steady and a little unglamorous. One is in the closing stages of being bought by an American rival; another has spent years fielding approaches while quietly slimming down; the third has just sold a prized division, promised Cash Back to shareholders and slipped out of the FTSE 100. As at 16 September 2026 all three remain FTSE 250 constituents, but the reasons each is in focus could hardly be more different.
Tate & Lyle (LSE:TATE)
Tate & Lyle is no longer the sugar refiner of popular memory. After selling control of its bulk sweeteners arm in 2022 and buying speciality ingredients group CP Kelco in 2024, it has become a pure-play supplier of sweeteners, texturants, dietary fibres and functional ingredients to global food and drink manufacturers. The dominant story of 2026, however, is corporate rather than operational. On 8 June the board agreed to a recommended all-cash Acquisition by US ingredients maker Ingredion at 595 pence per share, valuing the Equity at roughly £2.7 billion. Shareholders approved the deal on 28 July, and it has since been working through the regulatory clearances needed before completion — which explains the stream of Takeover Panel disclosure forms filling the company's news feed. For readers, the honest picture is that Tate & Lyle is a takeover in progress rather than a normal trading story. If the acquisition completes on the agreed terms, the shares will be cancelled and the company will leave the FTSE 250 altogether. The principal uncertainties now are timing and whether competition or foreign-investment reviews impose any conditions, so investors are watching the clearance timetable rather than the next set of results.
Elementis (LSE:ELM)
If Tate & Lyle is the deal that got done, Elementis is the one the market keeps expecting. The specialty chemicals group makes performance additives and rheology modifiers — the ingredients that control how coatings, cosmetics and industrial fluids flow and set — and holds valuable positions in hectorite clays and talc. It has been a perennial bid candidate: it previously rejected an approach from US group Innospec valued at around £1 billion, and private-equity firm KPS was later reported to have explored an offer. No firm bid is on the table today, but the shares have a habit of moving whenever speculation resurfaces. Operationally, 2026 has been a year of focus. Elementis reported full-year 2025 results on 5 March, issued a first-quarter update on 29 April, and on 2 June announced the sale of its pharma Business alongside a share buyback that began the following day. Half-year results on 30 July pointed to solid first-half growth. Slimming the portfolio and returning cash can cut both ways for a company like this — it sharpens the core, but a leaner, cheaper business can also look more digestible to a determined buyer. The risks are the familiar ones for a specialty chemicals maker: cyclical end-markets and swings in exchange rates.
Johnson Matthey (LSE:JMAT)
Johnson Matthey has spent 2026 remaking itself. The catalysts and precious-metals group was demoted from the FTSE 100 to the FTSE 250 earlier in the year — dropping out alongside Darktrace in a quarterly reshuffle — after a long stretch of share-price weakness. Its response has been decisive portfolio action. On 17 July it completed the sale of its Catalyst Technologies business to Honeywell for £1.325 billion, a price that had been trimmed by more than a quarter from the terms first floated, and it earmarked around £1 billion for return to shareholders, later carrying out a share consolidation to reflect the payout. Days after that disposal it completed the purchase of Cormetech, a US emissions-control specialist, having reported full-year results on 28 May. The strategy is to concentrate on Clean Air catalytic systems, platinum-group-metal services and hydrogen-related technologies. The wager is that a smaller, cash-rich Johnson Matthey can be valued more clearly than the sprawling group of old. The obvious risks are its continued exposure to the automotive and precious-metals cycles and the challenge of proving that the leaner business can grow rather than merely shrink.
How the Three Companies Compare
The common thread is not a shared end-market — sweeteners, coatings additives and catalytic converters have little in common — but a shared pressure. In each case value has been pursued through corporate action rather than organic growth alone. Tate & Lyle is nearly through a full takeover; Elementis is the recurring target reshaping itself in public; Johnson Matthey has chosen self-help, selling a business, returning cash and accepting a lower index berth in the hope of a cleaner Investment story. All three illustrate why UK mid-cap industrials have drawn overseas buyers and activists in recent years: persistent valuation discounts, strong niche positions and, in several cases, cash or Assets that can be crystallised.
What to Watch Next
For Tate & Lyle, the questions are almost entirely deal-related: the pace of regulatory clearances, any conditions attached, and the confirmed completion and delisting date. For Elementis, watch whether the disposal and buyback either invite a fresh approach or simply support the core, and how first-half momentum carries into the second half. For Johnson Matthey, the tests are delivery of the promised Capital return, the performance of the retained divisions, and whether management can rebuild a case for eventual re-entry to the FTSE 100.
Taken together, the trio is a reminder that for UK mid-caps in 2026, corporate change — who is buying, selling or breaking up — has become at least as important to returns as the underlying trading. None of this is a recommendation to buy or sell. It is a map of where the pressure points lie, and of the very different journeys three long-standing British industrials are now taking.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...